| 000 | 01757 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514071751.0 | ||
| 264 | 0 | _c20030728 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuroki, Tamotsu | |
| 245 | 0 | 0 |
_aAllelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bCancer research _cJun 2003 |
||
| 300 |
_a3352-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAzacitidine _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xgenetics |
| 650 | 0 | 4 |
_aChromosomes, Human, Pair 3 _xgenetics |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aGene Silencing |
| 650 | 0 | 4 | _aGenes, Tumor Suppressor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLoss of Heterozygosity |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xdeficiency |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xdeficiency |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 | _aSemaphorins |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 700 | 1 | _aTrapasso, Francesco | |
| 700 | 1 | _aYendamuri, Sai | |
| 700 | 1 | _aMatsuyama, Ayumi | |
| 700 | 1 | _aAlder, Hansjuerg | |
| 700 | 1 | _aWilliams, Noel N | |
| 700 | 1 | _aKaiser, Larry R | |
| 700 | 1 | _aCroce, Carlo M | |
| 773 | 0 |
_tCancer research _gvol. 63 _gno. 12 _gp. 3352-5 |
|
| 999 |
_c12594651 _d12594651 |
||